Juan Francisco
Navarro González
Investigador Externo
Universidad Autónoma de Madrid
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Universidad Autónoma de Madrid (17)
2023
-
From cardiorenal syndromes to cardionephrology: a reflection by nephrologists on renocardiac syndromes
Clinical Kidney Journal, Vol. 16, Núm. 1, pp. 19-29
-
Mineral and bone metabolism markers and mortality in diabetic patients on haemodialysis
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, Vol. 38, Núm. 11, pp. 2589-2597
-
Targeting inflammation to treat diabetic kidney disease: the road to 2030
Kidney International, Vol. 103, Núm. 2, pp. 282-296
-
The Value of Klotho in Kidney Transplantation
Transplantation, Vol. 107, Núm. 3, pp. 616-627
2022
-
RICORS2040: The need for collaborative research in chronic kidney disease
Clinical Kidney Journal, Vol. 15, Núm. 3, pp. 372-387
-
Repurposing drugs for highly prevalent diseases: pentoxifylline, an old drug and a new opportunity for diabetic kidney disease
Clinical Kidney Journal, Vol. 15, Núm. 12, pp. 2200-2213
-
Sodium-glucose co-transporter-2 inhibitors increase Klotho in patients with diabetic kidney disease: A clinical and experimental study
Biomedicine and Pharmacotherapy, Vol. 154
-
The unmet need of evidence-based therapy for patients with advanced chronic kidney disease and heart failure
Clinical Kidney Journal, Vol. 15, Núm. 5, pp. 865-872
2021
-
Developing the subspecialty of cardio-nephrology: The time has come. A position paper from the coordinating committee from the Working Group for Cardiorenal Medicine of the Spanish Society of Nephrology
Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia, Vol. 41, Núm. 4, pp. 391-402
-
Developing the subspecialty of cardio-nephrology: The time has come. A position paper from the coordinating committee from the Working Group for Cardiorenal Medicine of the Spanish Society of Nephrology
Nefrologia, Vol. 41, Núm. 4, pp. 391-402
2020
-
GLP-1 receptor agonists and diabetic kidney disease: A call of attention to nephrologists
Journal of Clinical Medicine, Vol. 9, Núm. 4
-
SGLT2 inhibitors for non-diabetic kidney disease: Drugs to treat CKD that also improve glycaemia
Clinical Kidney Journal, Vol. 13, Núm. 5, pp. 728-733
2019
-
Pentoxifylline for renal protection in diabetic kidney disease. A model of old drugs for new horizons
Journal of Clinical Medicine, Vol. 8, Núm. 3
2017
-
ERBP guideline on management of patients with diabetes and chronic kidney disease stage 3B or higher. Metformin for all?
Nefrologia, Vol. 37, Núm. 6, pp. 567-571
2016
-
Implications of Fibroblast growth factor/Klotho system in glucose metabolism and diabetes
Cytokine and Growth Factor Reviews
2012
-
Beyond proteinuria: VDR activation reduces renal inflammation in experimental diabetic nephropathy
American Journal of Physiology - Renal Physiology, Vol. 302, Núm. 6